09:11 AM EDT, 08/16/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Friday it completed its $3.2 billion acquisition of Morphic Holding ( MORF ) .
Morphic ( MORF ) shares will now be delisted from the Nasdaq Global Market, Lilly said
Lilly acquired Morphic ( MORF ), a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases, for $57 per share in cash.
Price: 911.75, Change: +3.70, Percent Change: +0.41